News
Pfizer said Health Canada has approved its latest COVID-19 vaccine that targets a new Omicron variant. It will be made available in the fall.
Pfizer Canada and BioNTech Receive Health Canada Approval of LP.8.1 Variant Adapted COVID-19 Vaccine
Pfizer Canada ULC and BioNTech SE (Nasdaq: BNTX) "BioNTech" announced today that Health Canada has authorized the LP.8.1 ...
Pfizer's Canadian unit and BioNTech said they have received approval in Canada for their updated Comirnaty Covid-19 vaccine. The companies said Monday the updated vaccine targets the Omicron LP.8.1 ...
On World Humanitarian Day, Pfizer Canada is proud to mark 30 years of partnership with Health Partners International of Canada (HPIC), a collaboration that has delivered over $70 million worth of life ...
TORONTO, Aug. 22, 2025 /CNW/ - With thousands of press releases published each week, it can be difficult to keep up with ...
Pfizer Canada (PFE) and BioNTech (BNTX) announced that Health Canada has authorized the LP.8.1 variant adapted COMIRNATY COVID-19 vaccine for ...
SOURCE Pfizer Canada Inc. Corporate Affairs Canada, Pfizer Canada Media Line: 1-866-9Pfizer (1 866 973-4937), [email protected] ...
Canada follows the U.K. and Bahrain in authorizing Pfizer's vaccine. The drugmaker has signed an agreement to supply Canada with a minimum of 20 million doses and a maximum of 76 million doses ...
Health Canada has approved Pfizer's adeno-associated viral (AAV) vector-based gene therapy, Beqvez, for the treatment of certain adults with hemophilia B, the company said Wednesday.
Pfizer's vaccine should be shipped by Friday, with doses arriving in Canada as early as Monday, said Major General Dany Fortin, who is leading the Canada's vaccine distribution effort, during a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results